Cargando…
BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity
BACKGROUND: In developed countries, the most common gynecologic malignancy is endometrial carcinoma (EC), making the identification of EC biomarkers extremely essential. As a natural enzyme, butyrylcholinesterase (BCHE) is found in hepatocytes and plasma. There is a strong correlation between BCHE g...
Autores principales: | Liu, Junxiu, Tian, Tian, Liu, Xiangyu, Cui, Zhumei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338740/ https://www.ncbi.nlm.nih.gov/pubmed/35915658 http://dx.doi.org/10.1155/2022/6051092 |
Ejemplares similares
-
Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapy
por: Gensthaler, Lisa, et al.
Publicado: (2023) -
Obesity and variants of the GHRL (ghrelin) and BCHE (butyrylcholinesterase) genes
por: Dantas, Vitor G.L., et al.
Publicado: (2011) -
Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development
por: Gu, Yan, et al.
Publicado: (2018) -
KIF2C Is a Novel Prognostic Biomarker and Correlated with Immune Infiltration in Endometrial Cancer
por: An, Lanfen, et al.
Publicado: (2021) -
Exploring the role of BCHE in the onset of Diabetes, Obesity and Neurological Disorders
por: Rao, Allam Appa, et al.
Publicado: (2012)